SEC Comment Letter for CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Mar 19, 2018
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: March 19, 2018 · CIK: 0001175680 · Accession: 0000000000-18-008339
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-223563
Letter
March 16, 2018 Nader Pourhassan, Ph.D. Chief Executive Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 Re:CytoDyn Inc. Registration Statement on Form S-3 Filed March 9, 2018 File No. 333-223563 Dear Dr. Pourhassan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Ada D. Sarmento at 202-551-3798 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Steven M. Skolnick, Esq.
Show Raw Text
March 16, 2018
Nader Pourhassan, Ph.D.
Chief Executive Officer
CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
Re:CytoDyn Inc.
Registration Statement on Form S-3
Filed March 9, 2018
File No. 333-223563
Dear Dr. Pourhassan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Ada D. Sarmento at 202-551-3798 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Steven M. Skolnick, Esq.